Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial

BACKGROUND: Stereotactic arrhythmia radioablation (STAR) is delivered with a planning target volume (PTV) prescription dose of 25 Gy, mostly to the surrounding 75–85% isodose line. This means that the average and maximum dose received by the target is less than 35 Gy, which is the minimum threshold...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovacs, Boldizsar, Mayinger, Michael, Ehrbar, Stefanie, Fesslmeier, Debra, Ahmadsei, Maiwand, Sazgary, Lorraine, Manka, Robert, Alkadhi, Hatem, Ruschitzka, Frank, Duru, Firat, Papachristofilou, Alexandros, Sticherling, Christian, Blamek, Slawomir, Gołba, Krzysztof S., Guckenberger, Matthias, Saguner, Ardan M., Andratschke, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634182/
https://www.ncbi.nlm.nih.gov/pubmed/37941012
http://dx.doi.org/10.1186/s13014-023-02361-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634182/
https://www.ncbi.nlm.nih.gov/pubmed/37941012
http://dx.doi.org/10.1186/s13014-023-02361-x

Ejemplares similares